HIM
AGN

Hermes Investment Management’s Allergan plc AGN Stock Holding History

Hermes Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,663
Closed -$404K – 230
2017
Q2 		$404K Buy
+1,663
New +$391K 0.01% 199
2017
Q1 		– Sell
-1,663
Closed -$349K – 229
2016
Q4 		$349K Hold
1,663
– – 0.01% 210
2016
Q3 		$383K Hold
1,663
– – 0.01% 202
2016
Q2 		$384K Hold
1,663
– – 0.01% 198
2016
Q1 		$446K Hold
1,663
– – 0.01% 195
2015
Q4 		$520K Hold
1,663
– – 0.01% 188
2015
Q3 		$452K Hold
1,663
– – 0.01% 185
2015
Q2 		$505K Hold
1,663
– – 0.01% 193
2015
Q1 		$495K Hold
1,663
– – 0.01% 195
2014
Q4 		$428K Hold
1,663
– – 0.01% 205
2014
Q3 		$401K Buy
+1,663
New +$372K 0.01% 200

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Hermes Investment Management's AGN Position: Q3 2017 in Review

Hermes Investment Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,663 shares — an estimated $404K sold.

Hermes Investment Management first reported a position in AGN in Q3 2014 and held it in 11 quarters. The position peaked at $520K in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Hermes Investment Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Hermes Investment Management sold 1,663 Allergan plc shares in Q3 2017, an estimated $404K.
  • Hermes Investment Management first reported a position in Allergan plc in Q3 2014 and held it in 11 quarters.
  • Hermes Investment Management's Allergan plc position peaked at $520K in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Hermes Investment Management's 13F filing for Q3 2017, filed 18 Oct 2017.